From: Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer
No toxicity
Grade 1
Grade 2
Grade 3
Grade 4
Dyesthesia
12.8%
70.9%
11.6%
4.7%
0%
Paresthesia
5.7%
66.3%
19.8%
7%
1.2%